+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Central Nervous System Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Central Nervous System Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
Interferons Market Report 2026 - Product Thumbnail Image

Interferons Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Ethical Pharmaceuticals Market Report 2026 - Product Thumbnail Image

Ethical Pharmaceuticals Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
Thrombosis Drugs Market 2024-2028 - Product Thumbnail Image

Thrombosis Drugs Market 2024-2028

  • Report
  • August 2024
  • 144 Pages
  • Global
From
From
Lecanemab Injection Market - Global Forecast 2025-2032 - Product Thumbnail Image

Lecanemab Injection Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 198 Pages
  • Global
From
a4ß7 Integrin Antagonists Market - Global Forecast 2026-2032 - Product Thumbnail Image

a4ß7 Integrin Antagonists Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
From
From
Loading Indicator